source
- Future Directions in Metastatic Castration-Resistant Prostate CancerDr. Pedro Barata and Dr. Johann De Bono conclude the discussion by reflecting on the evolving future of radiopharmaceutical therapies in metastatic castration-resistant prostate cancer (mCRPC) and…onclive · 2mo ago↗ source
- Personalized Treatment Decision-Making in Metastatic Castration-Resistant Prostate CancerDr. Johann De Bono and Dr. Pedro Barata discuss the increasing complexity of personalized treatment decision-making in metastatic castration-resistant prostate cancer (mCRPC) as radiopharmaceutical…onclive · 2mo ago↗ source
- STAT+: What the Trump administration wants in its next FDA leaderLeaders want the next FDA commissioner to be someone who can rebuild trust, focus on food policy, and drive drug-approval reforms.